These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 34596829)
1. Triptolide Alleviates Podocyte Epithelial-Mesenchymal Transition via Kindlin-2 and EMT-Related TGF-β/Smad Signaling Pathway in Diabetic Kidney Disease. Ren L; Wan R; Chen Z; Huo L; Zhu M; Yang Y; Chen Q; Zhang X; Wang X Appl Biochem Biotechnol; 2022 Feb; 194(2):1000-1012. PubMed ID: 34596829 [TBL] [Abstract][Full Text] [Related]
2. Triptolide Improves Renal Injury in Diabetic Nephropathy Rats through TGF-β1/Smads Signal Pathway. Pang R; Gu D Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1905-1911. PubMed ID: 34530721 [TBL] [Abstract][Full Text] [Related]
3. [Low dose of triptolide ameliorates podocyte epithelial-mesenchymal transition induced by high dose of D-glucose via inhibiting Wnt3α/β-catenin signaling pathway activation]. Shi G; Wu W; Wan YG; Hex HW; Tu Y; Han WB; Liu BH; Liu YL; Wan ZY Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(1):139-146. PubMed ID: 29552824 [TBL] [Abstract][Full Text] [Related]
4. Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759. Jin J; Zhang Z; Chen J; Liu Y; Chen Q; Wang Q Cell Cycle; 2019 Nov; 18(22):3125-3136. PubMed ID: 31564202 [TBL] [Abstract][Full Text] [Related]
5. Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease. Xue M; Cheng Y; Han F; Chang Y; Yang Y; Li X; Chen L; Lu Y; Sun B; Chen L Int J Biol Sci; 2018; 14(11):1545-1557. PubMed ID: 30263007 [TBL] [Abstract][Full Text] [Related]
6. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose]. Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395 [TBL] [Abstract][Full Text] [Related]
7. [Triptolide combined with irbesartan synergistically blocks podocyte injury in a type 2 diabetes rat model]. Ma RX; Xu Y; Zhang J; Li YS; Liu LQ Zhonghua Nei Ke Za Zhi; 2012 Feb; 51(2):117-22. PubMed ID: 22490812 [TBL] [Abstract][Full Text] [Related]
8. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy. Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292 [TBL] [Abstract][Full Text] [Related]
9. Hesperetin inhibit EMT in TGF-β treated podocyte by regulation of mTOR pathway. Choi D; Kim CL; Kim JE; Mo JS; Jeong HS Biochem Biophys Res Commun; 2020 Jul; 528(1):154-159. PubMed ID: 32451085 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux. Jin J; Gong J; Zhao L; Zhang H; He Q; Jiang X J Diabetes; 2019 Oct; 11(10):826-836. PubMed ID: 30864227 [TBL] [Abstract][Full Text] [Related]
11. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway. Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821 [TBL] [Abstract][Full Text] [Related]
12. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy. Zhang M; Liu M; Xiong M; Gong J; Tan X J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431 [TBL] [Abstract][Full Text] [Related]
13. Indoxyl Sulfate Aggravates Podocyte Damage through the TGF-β1/Smad/ROS Signalling Pathway. Jia M; Lin L; Xun K; Li D; Wu W; Sun S; Qiu H; Jin D Kidney Blood Press Res; 2024; 49(1):385-396. PubMed ID: 38735279 [TBL] [Abstract][Full Text] [Related]
14. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway. Li Z; Hong Z; Peng Z; Zhao Y; Shao R Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584 [TBL] [Abstract][Full Text] [Related]
15. Apelin inhibited epithelial-mesenchymal transition of podocytes in diabetic mice through downregulating immunoproteasome subunits β5i. Yin J; Wang Y; Chang J; Li B; Zhang J; Liu Y; Lai S; Jiang Y; Li H; Zeng X Cell Death Dis; 2018 Oct; 9(10):1031. PubMed ID: 30301930 [TBL] [Abstract][Full Text] [Related]
16. Panax Notoginseng Ameliorates Podocyte EMT by Targeting the Wnt/β-Catenin Signaling Pathway in STZ-Induced Diabetic Rats. Xie L; Zhai R; Chen T; Gao C; Xue R; Wang N; Wang J; Xu Y; Gui D Drug Des Devel Ther; 2020; 14():527-538. PubMed ID: 32103895 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of FOXO1 ameliorates the podocyte epithelial-mesenchymal transition induced by high glucose in vitro and in vivo. Du M; Wang Q; Li W; Ma X; Wu L; Guo F; Zhao S; Huang F; Wang H; Qin G Biochem Biophys Res Commun; 2016 Mar; 471(4):416-22. PubMed ID: 26902117 [TBL] [Abstract][Full Text] [Related]
18. Capsaicin reduces blood glucose and prevents prostate growth by regulating androgen, RAGE/IGF-1/Akt, TGF-β/Smad signalling pathway and reversing epithelial-mesenchymal transition in streptozotocin-induced diabetic mice. Sun H; Wang Z; Tu B; Shao Z; Li Y; Han D; Jiang Y; Zhang P; Zhang W; Wu Y; Wu X; Liu CM Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; 397(10):7659-7671. PubMed ID: 38700794 [TBL] [Abstract][Full Text] [Related]
19. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy. Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813 [TBL] [Abstract][Full Text] [Related]
20. Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy. Tang F; Hao Y; Zhang X; Qin J Drug Des Devel Ther; 2017; 11():2813-2826. PubMed ID: 29033543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]